4.7 Article

Optimization of thiazole analogues of resveratrol for induction of NAD(P)H:quinone reductase 1 (QR1)

Journal

BIOORGANIC & MEDICINAL CHEMISTRY
Volume 20, Issue 24, Pages 7030-7039

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmc.2012.10.006

Keywords

NAD(P)H:quinone reductase 1; QR1 inducer; Chemoprevention; Resveratrol

Funding

  1. National Cancer Institute [P01 CA48112]

Ask authors/readers for more resources

NAD(P)H:quinone reductase 1 (QR1) belongs to a class of enzymes called cytoprotective enzymes. It exhibits its cancer protective activity mainly by inhibiting the formation of intracellular semiquinone radicals, and by generating alpha-tocopherolhydroquinone, which acts as a free radical scavenger. It is therefore believed that QR1 inducers can act as cancer chemopreventive agents. Resveratrol (1) is a naturally occurring stilbene derivative that requires a concentration of 21 mu M to double QR1 activity (CD = 21 mu M). The stilbene double bond of resveratrol was replaced with a thiadiazole ring and the phenols were eliminated to provide a more potent and selective derivative 2 (CD = 2.1 mu M). Optimizing the substitution pattern of the two phenyl rings and the central heterocyclic linker led to a highly potent and selective QR1 inducer 9o with a CD value of 0.087 mu M. (C) 2012 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Chemistry, Medicinal

Investigating the Antibacterial Activity of Biphenylthiazoles against Methicillin- and Vancomycin-Resistant Staphylococcus aureus (MRSA and VRSA)

Mohamed Hagras, Haroon Mohammad, Mohamed S. Mandour, Youssef A. Hegazy, Adel Ghiaty, Mohamed N. Seleem, Abdelrahman S. Mayhoub

JOURNAL OF MEDICINAL CHEMISTRY (2017)

Article Chemistry, Medicinal

Phenylthiazole Antibacterial Agents Targeting Cell Wall Synthesis Exhibit Potent Activity in Vitro and in Vivo against Vancomycin-Resistant Enterococci

Haroon Mohammad, Waleed Younis, Lu Chen, Christine E. Peters, Joe Pogliano, Kit Pogliano, Bruce Cooper, Jianan Zhang, Abdelrahman Mayhoub, Eric Oldfield, Mark Cushman, Mohamed N. Seleem

JOURNAL OF MEDICINAL CHEMISTRY (2017)

Article Chemistry, Medicinal

Phenylthiazoles with tert-Butyl side chain: Metabolically stable with anti-biofilm activity

Ahmed Kotb, Nader S. Abutaleb, Mohamed A. Seleem, Mohamed Hagras, Haroon Mohammad, Ashraf Bayoumi, Adel Ghiaty, Mohamed N. Seleem, Abdelrahman S. Mayhoub

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)

Article Chemistry, Medicinal

Biphenylthiazole antibiotics with an oxadiazole linker: An approach to improve physicochemical properties and oral bioavailability

Mohamed Hagras, Youssef A. Hegazy, Amr H. Elkabbany, Haroon Mohammad, Adel Ghiaty, Tamer M. Abdelghany, Mohamed N. Seleem, Abdelrahman S. Mayhoub

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)

Article Chemistry, Medicinal

Alkoxyphenyithiazoles with broad-spectrum activity against multidrug-resistant gram-positive bacterial pathogens

Moustafa ElAwamy, Haroon Mohammad, Abdelrahman Hussien, Nader S. Abutaleb, Mohamed Hagras, Rabah A. T. Serya, Azza T. Taher, Khaled A. M. Abouzid, Mohamed N. Seleem, Abdelrahman S. Mayhoub

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)

Article Chemistry, Medicinal

Potent 1,2,4-Triazino[5,6b]indole-3-thioether Inhibitors of the Kanamycin Resistance Enzyme Eis from Mycobacterium tuberculosis

Huy X. Ngo, Keith D. Green, Chathurada S. Gajadeera, Melisa J. Willby, Selina Y. L. Holbrook, Caixia Hou, Atefeh Garzan, Abdelrahman S. Mayhoub, James E. Posey, Oleg Tsodikov, Sylvie Garneau-Tsodikova

ACS INFECTIOUS DISEASES (2018)

Article Chemistry, Medicinal

Naphthylthiazoles: Targeting Multidrug-Resistant and Intracellular Staphylococcus aureus with Biofilm Disruption Activity

Mohamed Hagras, Nader S. Abutaleb, Alsagher O. Ali, Jelan A. Abdel-Aleem, Mohamed M. Elsebaei, Mohamed N. Seleem, Abdelrahman S. Mayhoub

ACS INFECTIOUS DISEASES (2018)

Article Chemistry, Medicinal

Phenylthiazoles with nitrogenous side chain: An approach to overcome molecular obesity

Mohamed M. Elsebaei, Nader S. Abutaleb, Abdulrahman A. Mahgoub, Daoyi Li, Mohamed Hagras, Haroon Mohammad, Mohamed N. Seleem, Abdelrahman S. Mayhoub

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)

Article Chemistry, Medicinal

Balancing Physicochemical Properties of Phenylthiazole Compounds with Antibacterial Potency by Modifying the Lipophilic Side Chain

Ahmed Mancy, Nader S. Abutaleb, Mohamed M. Elsebaei, Abdullah Y. Saad, Ahmed Kotb, Alsagher O. Ali, Jelan A. Abdel-Aleem, Haroon Mohammad, Mohamed N. Seleem, Abdelrahman S. Mayhoub

ACS INFECTIOUS DISEASES (2020)

Article Chemistry, Medicinal

Modifying the lipophilic part of phenylthiazole antibiotics to control their drug-likeness

Yomna Hosny, Nader S. Abutaleb, Mariam Omara, Marwa Alhashimi, Mohamed M. Elsebaei, Heba S. Elzahabi, Mohamed N. Seleem, Abdelrahman S. Mayhoub

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)

Article Chemistry, Medicinal

Oxadiazolylthiazoles as novel and selective antifungal agents

Mohamed Hagras, Ehab A. Salama, Ahmed M. Sayed, Nader S. Abutaleb, Ahmed Kotb, Mohamed N. Seleem, Abdelrahman S. Mayhoub

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)

Article Chemistry, Medicinal

Exploring the structure-activity relationships of diphenylurea as an antibacterial scaffold active against methicillin- and vancomycin- resistant Staphylococcus aureus

Mohamed M. Elsebaie, Hanzada T. Nour El-Din, Nader S. Abutaleb, Abdelrahman A. Abuelkhir, Hsin-Wen Liang, Ahmed S. Attia, Mohamed N. Seleem, Abdelrahman S. Mayhoub

Summary: A series of diphenylurea derivatives with aminoguanidine moiety were synthesized and their antibacterial activity was evaluated. Two compounds showed better bacteriological profiles and prolonged post-antibiotic effect. Additionally, these compounds were able to resensitize vancomycin-resistant strains and exhibited comparable efficacy to a commercially available drug in a mouse model. Therefore, the diphenylurea scaffold has potential as an anti-staphylococcal treatment option.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)

Article Biochemistry & Molecular Biology

Expanding the structure-activity relationships of alkynyl diphenylurea scaffold as promising antibacterial agents

Hanzada T. Nour T. El-Din, Mohamed M. Elsebaie, Nader S. Abutaleb, Ahmed M. M. Kotb, Ahmed S. Attia, Mohamed N. Seleem, Abdelrahman S. Mayhoub

Summary: In this study, a series of structurally related acetylenic-diphenylurea derivatives carrying the aminoguanidine moiety were tested for their antibacterial efficacy against multidrug-resistant Gram-positive clinical isolates. Compound 18 showed superior bacteriological characteristics compared to the lead compound I. In addition, compound 18 demonstrated excellent in vitro antibacterial profile, high tolerability towards mammalian cells, and significant effectiveness in controlling MRSA infection in an animal model.

RSC MEDICINAL CHEMISTRY (2023)

Review Chemistry, Multidisciplinary

Peptidoglycan pathways: there are still more!

Ahmed M. Helal, Ahmed M. Sayed, Mariam Omara, Mohamed M. Elsebaei, Abdelrahman S. Mayhoub

RSC ADVANCES (2019)

Article Chemistry, Multidisciplinary

tert-Butylphenylthiazoles with an oxadiazole linker: a novel orally bioavailable class of antibiotics exhibiting antibiofilm activity

Ahmed Kotb, Nader S. Abutaleb, Mohamed Hagras, Ashraf Bayoumi, Mahmoud M. Moustafa, Adel Ghiaty, Mohamed N. Seleem, Abdelrahman S. Mayhoub

RSC ADVANCES (2019)

No Data Available